Role of the Fas/Fas ligand death receptor pathway in ginseng saponin metabolite-induced apoptosis in HepG2 cells

被引:37
作者
Oh, SH
Yin, HQ
Lee, BH
机构
[1] Wonkwang Univ, Coll Pharm, Iksan 570749, Jeonbuk, South Korea
[2] Wonkwang Univ, Med Resources Res Ctr, Iksan 570749, Jeonbuk, South Korea
关键词
ginseng saponin metabolite; IH901; HepG2; apoptosis; Fas/Fas ligand;
D O I
10.1007/BF02980081
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This research team found in previous studies, that the ginseng saponin metabolite IH901 induces apoptosis in HepG2 cells via a mitochondrial-mediated pathway, which resulted in the activation of caspase-9 and subsequently of caspase-3 and -8. Based on these results, the involvement of the Fas/Fas ligand (FasL) death-receptor pathway, in IH901-induced apoptosis in HepG2 cells, was investigated. Levels of Fas and the Fas ligand (FasL) mRNA or protein were not increased by IH901, rather they were decreased significantly at 18 h post treatment. Soluble FasL (sFasL) was detectable by immunoprecipitation analysis in the medium of HepG2 cells treated with IH901. Increased levels of sFasL were inversely correlated with the levels of FasL. Preincubation of HepG2 cells with antagonistic anti-Fas antibody showed little protective effect, if any, on IH901-induced cell death. At a 30 muM (24 and 48 h) and 40 muM (24 h) concentration of IH901, the cytotoxic effect of IH901 was less then 50%, anti-Fas antibody prevented IH901-induced cell death. However, at a 60 muM (24 and 48 h) and 40 muM (48 h) concentration of IH901, cell death rates were about 80% or more and most of the chemopreventive and chemotherapeutic effects of IH901 were manifested. Blocking the Fas receptor did not influence IH901-induced cell death. These results indicate that the Fas/FasL system is engaged, but not required for IH901-induced cell death, at pharmacologically significant concentrations.
引用
收藏
页码:402 / 406
页数:5
相关论文
共 31 条
[1]   Extracellular matrix interacts with soluble CD95L: Retention and enhancement of cytotoxicity [J].
Aoki, K ;
Kurooka, M ;
Chen, JJ ;
Petryniak, J ;
Nabel, EG ;
Nabel, GJ .
NATURE IMMUNOLOGY, 2001, 2 (04) :333-337
[2]   The tumor necrosis factor ligand and receptor families [J].
Bazzoni, F ;
Beutler, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) :1717-1725
[3]   Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease [J].
Braun, MY ;
Lowin, B ;
French, L ;
AchaOrbea, H ;
Tschopp, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) :657-661
[4]   Differential effects of membrane and soluble Fas ligand on cardiomyocytes: role in ischemia/reperfusion injury [J].
Date, T ;
Mochizuki, S ;
Belanger, AJ ;
Yamakawa, M ;
Luo, ZY ;
Vincent, KA ;
Cheng, SH ;
Gregory, RJ ;
Jiang, CW .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2003, 35 (07) :811-821
[5]   Soluble Fas-ligand (sFasL) in human astrocytoma cyst fluid is cytotoxic to T-cells: Another potential means of immune evasion [J].
Frankel, B ;
Longo, SL ;
Canute, GW .
JOURNAL OF NEURO-ONCOLOGY, 2000, 48 (01) :21-26
[6]   Main Ginseng saponin metabolites formed by intestinal bacteria [J].
Hasegawa, H ;
Sung, JH ;
Matsumiya, S ;
Uchiyama, M .
PLANTA MEDICA, 1996, 62 (05) :453-457
[7]   INHIBITORY EFFECT OF SOME TRITERPENOID SAPONINS ON GLUCOSE-TRANSPORT IN TUMOR-CELLS AND ITS APPLICATION TO IN-VITRO CYTOTOXIC AND ANTIVIRAL ACTIVITIES [J].
HASEGAWA, H ;
MATSUMIYA, S ;
UCHIYAMA, M ;
KUROKAWA, T ;
INOUYE, Y ;
KASAI, R ;
ISHIBASHI, S ;
YAMASAKI, K .
PLANTA MEDICA, 1994, 60 (03) :240-243
[8]   REVERSAL OF DAUNOMYCIN AND VINBLASTINE RESISTANCE IN MULTIDRUG-RESISTANT P388 LEUKEMIA IN-VITRO THROUGH ENHANCED CYTOTOXICITY BY TRITERPENOIDS [J].
HASEGAWA, H ;
SUNG, JH ;
MATSUMIYA, S ;
UCHIYAMA, M ;
INOUYE, Y ;
KASAI, R ;
YAMASAKI, K .
PLANTA MEDICA, 1995, 61 (05) :409-413
[9]   FAS AND PERFORIN PATHWAYS AS MAJOR MECHANISMS OF T-CELL-MEDIATED CYTOTOXICITY [J].
KAGI, D ;
VIGNAUX, F ;
LEDERMANN, B ;
BURKI, K ;
DEPRAETERE, V ;
NAGATA, S ;
HENGARTNER, H ;
GOLSTEIN, P .
SCIENCE, 1994, 265 (5171) :528-530
[10]   METALLOPROTEINASE-MEDIATED RELEASE OF HUMAN FAS LIGAND [J].
KAYAGAKI, N ;
KAWASAKI, A ;
EBATA, T ;
OHMOTO, H ;
IKEDA, S ;
INOUE, S ;
YOSHINO, K ;
OKUMURA, K ;
YAGITA, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) :1777-1783